Bruker Corp. buy Guggenheim
Start price
17.01.25
/
50%
€55.38
Target price
17.01.26
-
Performance (%)
-27.41%
End price
18.01.26
€40.20
Summary
This prediction ended on 18.01.26 with a price of €40.20. The price of Bruker Corp. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -27.41%. Guggenheim has a follow-up prediction for Bruker Corp. where he still thinks Bruker Corp. is a Buy. A total of €0.20 was paid as dividends for this prediction. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Bruker Corp. | -5.032% | -5.032% | -34.199% |
| iShares Core DAX® | 1.085% | -0.846% | 12.464% |
| iShares Nasdaq 100 | -1.665% | -3.306% | 1.502% |
| iShares Nikkei 225® | 3.863% | 6.308% | 22.272% |
| iShares S&P 500 | 0.111% | -1.337% | 1.101% |
Comments by Guggenheim for this prediction
In the thread Bruker Corp. diskutieren
Bruker Co. (NASDAQ: BRKR) had its "buy" rating re-affirmed by analysts at Guggenheim.
Ratings data for BRKR provided by MarketBeat
In the thread Trading Bruker Corp.
Die von Guggenheim gewählte maximale Laufzeit wurde überschritten